News
Inspired Advice: What Would You Tell Someone Who Has a Recurrence?
Those who have faced an ovarian or gynecologic cancer diagnosis have so much to offer to others going through a similar experience – be it support, tips or friendship…
Low-Grade Serous Ovarian Cancer | Ingrid’s #RareAware Story
Ingrid lives in Denver, Colorado, and was diagnosed with low-grade serous ovarian cancer in 2019. What has been your frustration in having a rare form of ovarian cancer? I was diagnosed in January of 2019 with low-grade serous ovarian cancer…
The Overview: July 2021
Sultry summer days can make anyone feel lazy and daydream of faraway places. But at OCRA, we’re working as hard as ever to fulfill our dream of a day when no one need fear an ovarian cancer diagnosis…
OCRA’s Statement on the Introduction of HR 4412 to Reauthorize Johanna’s Law
Your Representative needs to hear from YOU…
Does Ovarian Cancer Stop Periods?
No, ovarian cancer does not stop your period in and of itself. It is still possible to menstruate with the presence of the disease in your body…
Oral Contraceptives Associated with Lower Ovarian Cancer Risk in BRCA Mutation Carriers
A study published in the American Journal of Obstetrics & Gynecology provides new insight into previously established research that oral contraceptive use is connected to lower ovarian cancer risk in the general population, by more closely…
OCRA-Funded Study Identifies Antibiotic Found to Kill Tumor Cells Containing BRCA Mutations
A long-running study from Dana-Farber Cancer Institute, published in Nature Cancer and co-funded by OCRA, has discovered that the antibiotic novobiocin is capable of targeting and killing tumor cells in laboratory cell lines and tumor models with…
Racing to Cure Ovarian Cancer | Heroes Highlights
As our community continues to come together to make strides against ovarian cancer, we want to give a shout-out to our many OCRA Heroes who push themselves physically, creatively or in myriad other ways to raise money for research…
OCRA’s Woman to Woman Program Touted in Qualitative Study
Researchers from the University of Kansas School of Medicine conducted a study to capture the value and experience of giving and receiving peer support in the face of a gynecologic cancer diagnosis by interviewing Woman to Woman mentors…
What is Lynch Syndrome?
Inherited gene mutations, such as BRCA 1 and BRCA 2, can increase the risk of developing ovarian cancer. Some of these mutations, which affect MLH1, MSH2, MSH6, PMS2 and EPCAM genes, can cause Lynch Syndrome…
Seeking New Insights Into Origins of Ovarian Cancer | Meet a Scientist
“It’s kind of like how the Apollo mission to the moon gave us Velcro.” Dr…
Be #RareAware for Rare Ovarian Cancers
Many people are surprised to learn that ovarian cancer is not one disease, but several distinct types and subtypes. Each type differs in who it typically affects, how it spreads, how it’s treated, and its prognosis…